BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34024019)

  • 1. Up-regulation of pro-angiogenic molecules and events does not relate with an angiogenic switch in metastatic osteosarcoma cells but to cell survival features.
    Gutiérrez LM; Valenzuela Alvarez M; Yang Y; Spinelli F; Cantero MJ; Alaniz L; García MG; Kleinerman ES; Correa A; Bolontrade MF
    Apoptosis; 2021 Aug; 26(7-8):447-459. PubMed ID: 34024019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.
    Jia SF; Guan H; Duan X; Kleinerman ES
    J Exp Ther Oncol; 2008; 7(2):89-97. PubMed ID: 18771083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
    Koshkina N; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.
    Huang G; Nishimoto K; Zhou Z; Hughes D; Kleinerman ES
    Cancer Res; 2012 Feb; 72(4):908-16. PubMed ID: 22186140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.
    Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES
    Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
    Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
    Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systems biology approach reveals common metastatic pathways in osteosarcoma.
    Flores RJ; Li Y; Yu A; Shen J; Rao PH; Lau SS; Vannucci M; Lau CC; Man TK
    BMC Syst Biol; 2012 May; 6():50. PubMed ID: 22640921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of stem associated-features on metastatic osteosarcoma cells and their functional effects on mesenchymal stem cells.
    Álvarez MV; Gutiérrez LM; Auzmendi J; Correa A; Lazarowski A; Bolontrade MF
    Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129522. PubMed ID: 31945406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
    Gordon N; Kleinerman ES
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas expression in metastatic osteosarcoma cells is not regulated by CpG island methylation.
    Huang G; Koshkina NV; Kleinerman ES
    Oncol Res; 2009; 18(1):31-9. PubMed ID: 19911702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
    Huang G; Nishimoto K; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells.
    Duan X; Jia SF; Zhou Z; Langley RR; Bolontrade MF; Kleinerman ES
    Clin Exp Metastasis; 2004; 21(8):747-53. PubMed ID: 16035619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered morphology, nuclear stability and adhesion of highly metastatic derivatives of osteoblast-like SAOS-2 osteosarcoma cells.
    Muff R; Nigg N; Gruber P; Walters D; Born W; Fuchs B
    Anticancer Res; 2007; 27(6B):3973-9. PubMed ID: 18225558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of FAS Receptor Methylation in Osteosarcoma Metastasis.
    Sun JM; Chow WY; Xu G; Hicks MJ; Nakka M; Shen J; Ng PKS; Taylor AM; Yu A; Farrar JE; Barkauskas DA; Gorlick R; Guidry Auvil JM; Gerhard D; Meltzer P; Guerra R; Man TK; Lau CC; On Behalf Of The Target Osteosarcoma Consortium
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteosarcoma cells exhibit functional interactions with stromal cells, fostering a lung microenvironment conducive to the establishment of metastatic tumor cells.
    Valenzuela Alvarez MJP; Gutierrez LM; Bayo JM; Cantero MJ; Garcia MG; Bolontrade MF
    Mol Biol Rep; 2024 Mar; 51(1):467. PubMed ID: 38551765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases.
    Gordon N; Kleinerman ES
    Cancer Treat Res; 2009; 152():497-508. PubMed ID: 20213411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
    Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
    J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Metastatic and Anti-Angiogenic Effects of Curcumin Analog DK1 on Human Osteosarcoma Cells In Vitro.
    Aziz MNM; Rahim NFC; Hussin Y; Yeap SK; Masarudin MJ; Mohamad NE; Akhtar MN; Osman MA; Cheah YK; Alitheen NB
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34204873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.